These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 35699766)

  • 21. Central Venous Catheter Utilization and Complications in the Pediatric Cardiac ICU: A Report From the Pediatric Cardiac Critical Care Consortium (PC4).
    DiPietro LM; Gaies M; Banerjee M; Donohue JE; Zhang W; DeSena HC; Graham EM; Sasaki J; Moga MA; Prodhan P; Goldstein SL; Tabbutt S; Cooper DS
    Pediatr Crit Care Med; 2020 Aug; 21(8):729-737. PubMed ID: 32453921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do neonates, infants and young children need a higher dose of enoxaparin in the cardiac intensive care unit?
    Sanchez de Toledo J; Gunawardena S; Munoz R; Orr R; Berry D; Sonderman S; Krallman S; Shiderly D; Wang L; Wearden P; Morell VO; Chrysostomou C
    Cardiol Young; 2010 Apr; 20(2):138-43. PubMed ID: 20199704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of anti-factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxis.
    Pannucci CJ; Prazak AM; Scheefer M
    Am J Surg; 2017 Jun; 213(6):1143-1152. PubMed ID: 27692434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioactivity of enoxaparin in critically ill patients with normal renal function.
    Gouya G; Palkovits S; Kapiotis S; Madl C; Locker G; Stella A; Wolzt M; Heinz G
    Br J Clin Pharmacol; 2012 Nov; 74(5):806-14. PubMed ID: 23227470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of antithrombin III and enoxaparin dosage adjustment on prophylactic anti-Xa concentrations in trauma patients at high risk for venous thromboembolism: a randomized pilot trial.
    Droege ME; Droege CA; Philpott CD; Webb ML; Ernst NE; Athota K; Wakefield D; Dowd JR; Gomaa D; Robinson BHR; Hanseman D; Elterman J; Mueller EW
    J Thromb Thrombolysis; 2021 Nov; 52(4):1117-1128. PubMed ID: 33978907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients.
    Bigos R; Solomon E; Dorfman JD; Ha M
    J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
    Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
    JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fixed-dose enoxaparin provides efficient DVT prophylaxis in mixed ICU patients despite low anti-Xa levels: A prospective observational cohort study.
    Benes J; Skulec R; Jobanek J; Cerny V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):204-210. PubMed ID: 34042098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
    Pelland-Marcotte MC; Amiri N; Avila ML; Brandão LR
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD005982. PubMed ID: 32557627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients.
    Ludwig KP; Simons HJ; Mone M; Barton RG; Kimball EJ
    Ann Pharmacother; 2011 Nov; 45(11):1356-62. PubMed ID: 22009998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
    Weitz JI; Bauersachs R; Becker B; Berkowitz SD; Freitas MCS; Lassen MR; Metzig C; Raskob GE
    JAMA; 2020 Jan; 323(2):130-139. PubMed ID: 31935028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary Anticoagulation Prophylaxis for Catheter-Related Thrombosis in Pediatric Intestinal Failure: Comparison of Short- Vs Long-Term Treatment Protocols.
    Schmidt ML; Wendel D; Horslen SP; Lane ER; Brandão LR; Gottschalk E; Belza C; Courtney-Martin G; Wales PW; Avitzur Y
    JPEN J Parenter Enteral Nutr; 2021 Sep; 45(7):1432-1440. PubMed ID: 33616995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery.
    Bara L; Planes A; Samama MM
    Br J Haematol; 1999 Feb; 104(2):230-40. PubMed ID: 10050702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One Size Does Not Fit All: Venous Thromboembolism Prophylaxis in Colorectal Cancer.
    Perrotti G; Sadri L; Fassler M; Sharma D; Kim S; Zebley M; Fassler S
    JSLS; 2020; 24(3):. PubMed ID: 32831542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IV Versus Subcutaneous Enoxaparin in Critically Ill Infants and Children: Comparison of Dosing, Anticoagulation Quality, Efficacy, and Safety Outcomes.
    Diab YA; Ramakrishnan K; Ferrell B; Chounoune R; Alfares FA; Endicott KM; Rooney S; Corcoran J; Zurakowski D; Berger JT; Shankar V; Nath DS
    Pediatr Crit Care Med; 2017 May; 18(5):e207-e214. PubMed ID: 28296662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
    Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peak plasma anti-Xa levels after first and third doses of enoxaparin in women receiving weight-based thromboprophylaxis following caesarean section: a prospective cohort study.
    Hiscock RJ; Casey E; Simmons SW; Walker SP; Newell PA
    Int J Obstet Anesth; 2013 Nov; 22(4):280-8. PubMed ID: 23958275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. If some is good, more is better: An enoxaparin dosing strategy to improve pharmacologic venous thromboembolism prophylaxis.
    Berndtson AE; Costantini TW; Lane J; Box K; Coimbra R
    J Trauma Acute Care Surg; 2016 Dec; 81(6):1095-1100. PubMed ID: 27244575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IV enoxaparin in pediatric and cardiac ICU patients.
    Cies JJ; Santos L; Chopra A
    Pediatr Crit Care Med; 2014 Feb; 15(2):e95-103. PubMed ID: 24335994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Underdosing of Prophylactic Enoxaparin Is Common in Orthopaedic Trauma and Predicts 90-Day Venous Thromboembolism.
    Jones DL; Jones WA; Fleming KI; Higgins TF; Rothberg DL; Zhang Y; Pannucci CJ
    J Orthop Trauma; 2019 Nov; 33(11):570-576. PubMed ID: 31634287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.